Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Pegvisomant> ?p ?o }
Showing triples 1 to 81 of
81
with 100 triples per page.
- Pegvisomant abstract "Pegvisomant (trade name Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly. It is used if the tumor of the pituitary gland causing the acromegaly cannot be controlled with surgery or radiation, and the use of somatostatin analogues is unsuccessful. It is delivered as a powder that is mixed with water and injected under the skin.".
- Pegvisomant atcPrefix "H01".
- Pegvisomant atcSuffix "AX01".
- Pegvisomant casNumber "218620-50-9".
- Pegvisomant drugbank "DB00082".
- Pegvisomant fdaUniiCode "N824AOU5XV".
- Pegvisomant wikiPageID "14546023".
- Pegvisomant wikiPageLength "5886".
- Pegvisomant wikiPageOutDegree "18".
- Pegvisomant wikiPageRevisionID "692561498".
- Pegvisomant wikiPageWikiLink Acromegaly.
- Pegvisomant wikiPageWikiLink Amino_acid.
- Pegvisomant wikiPageWikiLink Category:Pfizer_products.
- Pegvisomant wikiPageWikiLink Escherichia_coli.
- Pegvisomant wikiPageWikiLink Growth_hormone.
- Pegvisomant wikiPageWikiLink Growth_hormone_receptor.
- Pegvisomant wikiPageWikiLink Hepatitis.
- Pegvisomant wikiPageWikiLink Hypoglycemia.
- Pegvisomant wikiPageWikiLink Insulin-like_growth_factor_1.
- Pegvisomant wikiPageWikiLink PEGylation.
- Pegvisomant wikiPageWikiLink Pituitary_gland.
- Pegvisomant wikiPageWikiLink Polyethylene_glycol.
- Pegvisomant wikiPageWikiLink Protein.
- Pegvisomant wikiPageWikiLink Receptor_antagonist.
- Pegvisomant wikiPageWikiLink Somatostatin.
- Pegvisomant wikiPageWikiLink Subcutaneous_injection.
- Pegvisomant wikiPageWikiLinkText "Pegvisomant".
- Pegvisomant wikiPageWikiLinkText "pegvisomant".
- Pegvisomant atcPrefix "H01".
- Pegvisomant atcSuffix "AX01".
- Pegvisomant c "990".
- Pegvisomant casNumber "218620".
- Pegvisomant chembl "1201515".
- Pegvisomant chemspiderid "none".
- Pegvisomant drugbank "DB00082".
- Pegvisomant h "1532".
- Pegvisomant iupharLigand "7485".
- Pegvisomant kegg "D05394".
- Pegvisomant molecularWeight "22129".
- Pegvisomant n "262".
- Pegvisomant o "300".
- Pegvisomant s "7".
- Pegvisomant tradename "Somavert".
- Pegvisomant unii "N824AOU5XV".
- Pegvisomant verifiedfields "changed".
- Pegvisomant verifiedrevid "464197586".
- Pegvisomant wikiPageUsesTemplate Template:Cascite.
- Pegvisomant wikiPageUsesTemplate Template:Chemspidercite.
- Pegvisomant wikiPageUsesTemplate Template:Drugbankcite.
- Pegvisomant wikiPageUsesTemplate Template:Drugbox.
- Pegvisomant wikiPageUsesTemplate Template:Drugs.com.
- Pegvisomant wikiPageUsesTemplate Template:Ebicite.
- Pegvisomant wikiPageUsesTemplate Template:Fdacite.
- Pegvisomant wikiPageUsesTemplate Template:Keggcite.
- Pegvisomant wikiPageUsesTemplate Template:Peptidergics.
- Pegvisomant wikiPageUsesTemplate Template:Reflist.
- Pegvisomant subject Category:Pfizer_products.
- Pegvisomant hypernym Antagonist.
- Pegvisomant type ChemicalSubstance.
- Pegvisomant type Company.
- Pegvisomant type Drug.
- Pegvisomant type Chemical.
- Pegvisomant type Company.
- Pegvisomant type Redirect.
- Pegvisomant type ChemicalObject.
- Pegvisomant type Thing.
- Pegvisomant type Q8386.
- Pegvisomant comment "Pegvisomant (trade name Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly. It is used if the tumor of the pituitary gland causing the acromegaly cannot be controlled with surgery or radiation, and the use of somatostatin analogues is unsuccessful. It is delivered as a powder that is mixed with water and injected under the skin.".
- Pegvisomant label "Pegvisomant".
- Pegvisomant sameAs Q409697.
- Pegvisomant sameAs Pegvisomant.
- Pegvisomant sameAs Pegvisomant.
- Pegvisomant sameAs Pegvisomant.
- Pegvisomant sameAs Pegwisomant.
- Pegvisomant sameAs Pegvisomanto.
- Pegvisomant sameAs m.03d7b2m.
- Pegvisomant sameAs Pegvisomant.
- Pegvisomant sameAs Pegvisomant.
- Pegvisomant sameAs Q409697.
- Pegvisomant wasDerivedFrom Pegvisomant?oldid=692561498.
- Pegvisomant isPrimaryTopicOf Pegvisomant.